𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Betulinic acid: A new cytotoxic agent against malignant brain-tumor cells

✍ Scribed by Simone Fulda; Irmela Jeremias; Hans H. Steiner; Torsten Pietsch; Klaus-Michael Debatin

Book ID
101235210
Publisher
John Wiley and Sons
Year
1999
Tongue
French
Weight
183 KB
Volume
82
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis

Malignant brain tumors are the most common solid tumors in children. The overall prognosis for this group of patients is still poor, emphasizing the importance of more effective therapies. Betulinic acid (Bet A) has been described as a novel cytotoxic compound active against melanoma and neuroblastoma cells. Here we report that Bet A was active against medulloblastoma and glioblastoma cell lines. In addition, Bet A exerted cytotoxic activity against primary tumor cells cultured from patients in 4 of 4 medulloblastoma-tumor samples tested and in 20 of 24 glioblastoma-tumor samples. Since a small percentage of primary-glioblastoma-tumor cells (4/24) did not respond to Bet-A treatment, resistance to Bet A might occur. Induction of apoptosis by Bet A involved mitochondrial perturbations, since inhibition of the mitochondrial permeability transition by the mitochondrion-specific inhibitor bongkrekic acid (BA) reduced Bet-A-induced apoptosis. In addition, mitochondria undergoing Bet-A-induced permeability transition triggered DNA fragmentation in isolated nuclei. Cytochrome c was released from mitochondria of Bet-A-treated cells, and might be involved in activation of caspases. Following treatment with Bet A, caspase-8, caspase-3 and PARP were proteolytically processed. Inhibition of caspase cleavage by the broad-range caspase inhibitor zVAD.fmk strongly reduced Bet-A-induced apoptosis, indicating that apoptosis was mediated by activation of caspases. Since Bet A did not exhibit cytotoxicity against murine neuronal cells in vitro, these findings suggest that Bet A may be a promising new agent for the treatment of medulloblastoma and glioblastoma cells that clearly warrants further pre-clinical and clinical evaluation.

πŸ“œ SIMILAR VOLUMES

Betulinic acid: A new cytotoxic compound
Betulinic acid: A new cytotoxic compound against malignant head and neck cancer cells
✍ Dietmar Thurnher; Dritan Turhani; Martina Pelzmann; Bettina Wannemacher; Birgit πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 339 KB

## Background: A new compound, betulinic acid, has been found to be cytotoxic against a variety of tumor cells originating from the neural crest. its efficacy against head and neck squamous cellular carcinoma cell lines has so far not been tested. ## Methods: Cell numbers were assayed by automate

Betulinic acid, a natural cytotoxic agen
Betulinic acid, a natural cytotoxic agent, fails to trigger apoptosis in human Burkitt's lymphoma-derived B-cell lines
✍ Maria B. Karpova; Duangmanee Sanmun; Jan-Inge Henter; Aleksandr F. Smirnov; Beng πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 French βš– 675 KB

## Abstract Betulinic acid (BA), a pentacyclic triterpene of natural origin, effectively induces apoptosis in neuroectodermal tumors and was recently shown to be a potent trigger of cell death in human leukemia‐derived cell lines. To explore the potential of BA in the treatment of hematologic malig